Finance

Lists
Why is MTRI down 7.10%?
Dive Deeper
MTRI:NASDAQ
Mentari Therapeutics, Inc.
$14.20
-7.10%
(-1.08) 1D
Nov 19, 3:20:06 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MTRI...
Open
$14.90
High
$15.51
Low
$13.81
Mkt. cap
749.71M
Avg. vol.
24.25K
Volume
15.62K
52-wk high
$20.00
52-wk low
$12.20
EPS
-$29.15
Beta
0.94
Shares outstanding
52.81M
No. of employees
6
Open
$14.90
High
$15.51
Low
$13.81
Mkt. cap
749.71M
Avg. vol.
24.25K
Volume
15.62K
52-wk high
$20.00
52-wk low
$12.20
EPS
-$29.15
Beta
0.94
Shares outstanding
52.81M
No. of employees
6
News stories
From web sources and news partners
About Mentari Therapeutics, Inc.
CEOEric A. Adams
Employees6
Founded1981
HeadquartersWaltham, Massachusetts, United States
SectorHealth Care
IndustryBiotechnology
Analyst ratings
Based on 5 analysts giving stock ratings to MTRI in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for MTRI in the last 3 months.
Highest
Current $14.20
$42.00 (+195.77%)
Average
$33.75 (+137.68%)
Lowest
$30.00 (+111.27%)
Analyst
Recommendation
Action
Price target
Projected
Date
Laura Chico
Wedbush
Buy
Maintained
$33.00
+132.4%
11/17/2026
Tyler Van Buren
TD Cowen
Buy
Initiated
-
-
11/11/2026
Paul Matteis
Stifel Nicolaus
Buy
Initiated
$30.00
+111.3%
11/10/2026
Andrew Tsai
Jefferies
Buy
Initiated
$30.00
+111.3%
11/10/2026
Unknown Analyst
Guggenheim
Buy
Initiated
$42.00
+195.8%
11/09/2026
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Mar 2027
Revenue
820.19K
-
-
-
Cost of goods sold
635.99K
-
-
-
Cost of revenue
635.99K
-
-
-
Research and development expenses
630.64K
1.02M
805.74K
206.02K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.62M
1.74M
2.36M
1.80M
Operating expense
2.30M
2.82M
3.21M
2.01M
Total operating expenses
2.94M
2.82M
3.21M
2.01M
Operating income
-2.12M
-2.82M
-3.21M
-2.01M
Other non operating income
-
-
-
-
EBT including unusual items
-2.03M
-2.79M
-4.84M
-2.00M
EBT excluding unusual items
-2.03M
-2.79M
-3.19M
-2.00M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.03M
-2.97M
-5.84M
-2.33M
Net profit margin
-247.29%
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
74.38K
47.77K
29.06K
14.31K
Interest expense
-
-
-10.70K
-
Net interest expenses
74.38K
47.77K
18.36K
14.31K
Depreciation and amortization charges
53.20K
51.71K
48.36K
168.00
EBITDA
-2.07M
-2.77M
-3.16M
-2.01M
Gain or loss from assets sale
-
-
7.14K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps